TechsoMed
TechsoMed52TechsoMed
TechsoMed develops ultrasound-based real-time monitoring systems for thermal ablation procedures, enhancing safety and efficacy.
About
What does TechsoMed do?
TechsoMed is an Israeli medical device company focused on creating advanced ultrasound-based real-time monitoring systems for thermal ablation procedures. Their technology aims to improve the safety and efficacy of these procedures, which are used for various applications including tumor destruction, heart arrhythmia, and blood pressure treatments.
What is TechsoMed's revenue?
StartupHub estimates TechsoMed's annual revenue at $4.9M (range $2.7M to $8.8M, 67% confidence), based on comparable companies in the sector.
What is TechsoMed's valuation?
StartupHub estimates TechsoMed's effective valuation at $38.8M (range $24.0M to $57.6M, 10% confidence), based on comparable companies in the sector.
How much funding has TechsoMed raised?
TechsoMed has raised a total of $10M in funding. The most recent round on record is Series B.
Where is TechsoMed headquartered?
TechsoMed is headquartered in Tel Aviv, Israel.
When was TechsoMed founded?
TechsoMed was founded in 2012.
What industry does TechsoMed operate in?
TechsoMed operates in Healthcare, Medical Imaging, Ultrasound, MedTech, Medical Device, Ultrasound Imaging.
How many employees does TechsoMed have?
TechsoMed has approximately 26 people on record.
“FDA grants De Novo clearance to Techsomed's BioTraceIO, an AI-powered algorithm for real-time liver ablation analysis.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.